Pulmonx Corporation provided revenue guidance for the third quarter ended September 30, 2023. The company's total worldwide revenue for the third quarter of 2023 is anticipated to be approximately $17.6 million, representing growth of approximately 30% over the same quarter last year.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.82 USD | -1.27% |
|
-6.95% | -54.35% |
Jun. 04 | Lake Street Initiates Pulmonx With Buy Rating, $12 Price Target | MT |
May. 01 | Earnings Flash (LUNG) PULMONX CORPORATION Posts Q1 Revenue $18.9M, vs. Street Est of $17.9M | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-54.35% | 229M | |
+75.69% | 12.57B | |
+11.24% | 7.21B | |
-30.25% | 6.82B | |
+11.54% | 5.35B | |
-20.60% | 4.59B | |
+10.66% | 3.95B | |
-22.87% | 3.69B | |
-28.90% | 2.64B | |
+28.43% | 2.09B |
- Stock Market
- Equities
- LUNG Stock
- News Pulmonx Corporation
- Pulmonx Corporation Provides Revenue Guidance for the Third Quarter Ended September 30, 2023